BUNDLED NETWORK EXPERTISE IS A WINNING ARGUMENT. -- MEDICA - World Forum for Medicine

11.11.2021

WILD Gruppe

BUNDLED NETWORK EXPERTISE IS A WINNING ARGUMENT.

The relaunch of MEDICA/COMPAMED 2021 sees a sizeable WILD Group presence and a whole host of innovations. 

How can you combine different ideas to create an innovative product? Moreover, what distinguishes those specialists who develop and manufacture such high-tech devices using their experience, know-how and technical skill? The WILD Group will deliver illustrative answers to these questions at the MEDICA/ COMPAMED trade fair from 15 to 18 November 2021, offering visitors a glimpse behind the scenes of its success. And not only at the trade fair itself, where the senior management, members of the technical and business  development teams and CTO Wolfgang Warum will be present. „In addition, this year the group‘s development and production sites will be virtually present at the trade fair“, explains Heidrun Freimuth, WILD‘s expert for marketing and trade fairs. Potential new customers in particular will thus obtain a direct feel for how WILD works.

„Following two years without a trade fair and countless online meetings, we are really looking forward to a live relaunch of the real-life event, where we can exchange ideas face to face with experts and manufacturers on the latest technologies from the areas of medical & life sciences, in-vitro diagnostics and laboratory, laser and lighting technologies. This is why we took the conscious decision to send a large team to the fair“, says Freimuth. Exciting products from WIN network partner INSION GmbH will be complementing the trade fair portfolio of WILD and lighting specialist Photonic. The company is among the leading makers of monolithic microspectrometers and spectral sensors for OEM applications and miniature glass fibre optics.

A LOOK INTO THE FUTURE OF MEDICAL TECHNOLOGY
Two WILD experts will be present as part of the COMPAMED Suppliers Forum, to provide in-depth information on the topics of outsourcing and fluorescence technologies. On Monday 15 November, Business Development Manager Daniel Pressl will be speaking about the importance of outsourcing as a solution for the development and production of high-tech medical products. And, on Tuesday 16 November, Photonic Business Developer Joachim Enengl will be explaining the immense solution potential of fluorescence technologies. Using a set of different examples, he will be providing some insights into the photonic and optomechatronic engineering and manufacturing know-how applied by Photonic in the optimisation of diagnostic and interventional devices. 

Exhibitor Data Sheet